All Liver disease articles
-
NewsRecord-breaking rise in alcohol-related deaths during COVID
The rise in alcohol-related deaths was fuelled by increased levels of at-home drinking during lockdown, public health officials suggest
-
Sponsored algorithm
Management of hepatic encephalopathy in primary care
This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
View TARGAXAN® (rifaximin-α) prescribing and adverse event reporting information
UK-HEP-XIF-2100040 October 2021 -
On demand webinars
The second in a series of half-day virtual events focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Promotional information regarding Norgine Pharmaceutical Limited products will be presented during these webinars.
UK-COR-NP-2100090
Date of preparation: October 2021 -
News
BSG joint statement: COVID-19 booster vaccination and liver disease
The BSG has published a joint statement covering advice on COVID-19 booster vaccination for people with liver disease
-
On demand webinars
Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021 -
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
Independent professional body guideline
Early identification and referral of liver disease in infants
This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate.
-
Independent professional body guideline
CLDF guideline: Yellow Alert stool chart
A summary of the CLDF's Yellow Alert stool chart—for tracking the colour of newborn babies' stools and being alert to warning signs of prolonged jaundice.
-
Independent professional body guideline
BSG liver blood tests guideline
This summary covers the key points for GPs to consider when interpreting results from liver blood tests and how to respond to detected abnormalities.
-
NICE guideline
NICE non-alcoholic fatty liver disease guideline
A summary of NICE guidance on non-alcoholic fatty liver disease. Includes identification, lifestyle advice, and pharmacological treatment.
-
Feature article
Nurses play a crucial role in reducing the burden of liver disease
Michelle Clayton examines the current and future impact of liver disease and its causes, and highlights the role of nurses in educating and supporting patients to prevent the disease developing.
-
NICE guideline
NICE cirrhosis guideline
A useful and concise summary on the assessment and management of cirrhosis. Recommendations cover diagnosis, monitoring, and managing complications.
